← Open Payments lookup

MICHELLE CHMELECKI: Open Payments

NPI 1134456957 · PORTLAND, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$9,536 in 34 payments from 8 companies in 2025. Trend: 2023 $687 · 2024 $538 · 2025 $9,536

Debt forgiveness: $8,709Food & beverage: $827
CompanyPaymentsAmount
Neuronetics, Inc.1$8,709
ABBVIE INC.14$382
Otsuka America Pharmaceutical, Inc.9$221
Axsome Therapeutics, Inc.3$75
Neurocrine BioSciences, Inc.3$70
Corium, LLC2$31
Alkermes, Inc.1$28
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$19

Products named: NEUROSTAR TMS THERAPY SYSTEM, VRAYLAR, REXULTI, Auvelity, INGREZZA, Azstarys, ARISTADA, CAPLYTA.

Industry payments across ME — which companies pay providers there.